TradingView
RocketTickers
21 maj 2019 16:38
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal S
Long
NASDAQ:AKRX
Opis
⋅
21 maj 2019 16:38
AKRX: Akorn, Inc.
2019-05-20 16:05:00
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.1% - GlobeNewswire
Beyond Technical Analysis
Więcej